Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain
Open accessThe DOI matches its Crossref record.
Abstract
The effect of reboxetine, a novel antidepressant drug that potently and selectively inhibits neuronal noradrenaline (NA) uptake, on brain extracellular monoamines was studied by microdialysis. Fifteen mg kg−1 i.p. reboxetine raised extracellular NA in the frontal cortex (by 242%) and dorsal hippocampus (by 240%). Idazoxan (1 mg kg−1 s.c.), given 60 min after 15 mg kg−1 reboxetine, markedly potentiated the effect on extracellular NA in the frontal cortex (by 1580%) and dorsal hippocampus (by 1360%), but had no effect by itself. Twenty‐four hours after the last injection of a chronic schedule (15 mg kg−1 i.p. once daily for 14 days) reboxetine had no effect on basal extracellular concentrations of NA in the dorsal hippocampus and a challenge dose of reboxetine (15 mg kg−1) raised extracellular NA similarly in rats treated chronically with reboxetine (by 353%) and saline (by 425%). Ten and 20 μg kg−1 i.p. clonidine dose‐dependently reduced hippocampal extracellular NA similarly in rats given chronic reboxetine (by 32% and 57%) and saline (by 42% and 56%). Extracellular concentrations of dopamine and 5‐HT in the striatum were similar in rats treated chronically with reboxetine and saline. A challenge dose of reboxetine (15 mg kg−1) had no effect on striatal extracellular dopamine and slightly increased striatal extracellular 5‐HT to a similar extent in rats treated chronically with reboxetine (by 137%) and saline (by 142%). The results suggest that combining reboxetine with an α 2‐adrenoceptor antagonist may facilitate its antidepressant activity. Repeated treatment confirmed that reboxetine is fairly selective for the noradrenergic system but provided no evidence of adaptive changes in that system that could facilitate its effect on extracellular NA. British Journal of Pharmacology (1999) 128, 1332–1338; doi:10.1038/sj.bjp.0702926
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
“Reboxetine increased NEEX (Sacchetti et al. 1999) and DAEX in the PFC to similar levels and to about the same NEUROPSYCHOPHARMACOLOGY 2002–VOL. 27, NO. 5 Atomoxetine Increases Cortical Catecholamine Levels 707 magnitude as found with atomoxetine, consistent with previous reports (Linnèr et al.…”
BackgroundResultImmunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter
Schroeter, S., Apparsundaram, S., Wiley, R. G., Miner, L. H., Sesack, S. R., & Blakely, R. D. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000501)420:2<211::aid-cne5>3.0.co;2-3 · Cited by 281
Koda, K., Ago, Y., Cong, Y., Kita, Y., Takuma, K., & Matsuda, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06750.x · Cited by 222
Chen, M. J., & Russo‐Neustadt, A. A. (2009) · Hippocampus · doi:10.1002/hipo.20579 · Cited by 129
“On the other hand, more recent studies have examined cellular effects of very short-term antidepressant treatment, and a few agents increase BDNF expression within 4–6 h (Sacchetti et al., 1999; Dias et al., 2003; Saarelainen et al., 2003; Vaynman et al., 2003; Rantamaki et al., 2007).”
Noradrenergic neuromodulation of human attention for emotional and neutral stimuli
De Martino, B., Strange, B. A., & Dolan, R. J. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1015-5 · Cited by 103
Weikop, P., Kehr, J., & Scheel-Krüger, J. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800311 · Cited by 57
“An alternative augmentation approach is based on the concomitant blockade of adrenergic α2-autoreceptors and inhibition of noradrenaline reuptake, as studied by microdialysis in rats administered with idazoxan and reboxetine (Sacchetti et al., 1999) or idazoxan and sibutramine (Wortley et al.”
BackgroundNoradrenergic Hypothesis Linking Neurodegeneration-Based Cognitive Decline and Astroglia
Leanza, G., Gulino, R., & Zorec, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00254 · Cited by 54
Metadata
- Authors
- Sacchetti, G., Bernini, M., Bianchetti, A., Parini, S., Invernizzi, R. W., & Samanin, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-11
- Volume
- 128
- Issue
- 6
- Pages
- 1332-1338
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2044801311
- Cited by
- 100
- References
- 0
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.